paclitaxel has been researched along with Carcinoma, Neuroendocrine in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (3.85) | 18.2507 |
2000's | 5 (19.23) | 29.6817 |
2010's | 17 (65.38) | 24.3611 |
2020's | 3 (11.54) | 2.80 |
Authors | Studies |
---|---|
Fukada, M; Goto, A; Kumazawa, I; Mizuno, M; Nishio, K; Sano, H; Tanaka, K | 1 |
Kawai, Y; Kishigami, Y; Kondo, E; Kotaka, S; Nagao, K; Okamoto, K; Suzuki, S; Toru, H; Yamawaki, T | 1 |
He, M; Liu, D; Tuo, Y; Zeng, F | 1 |
Baum, V; Christopoulos, P; Eberhardt, W; Engel-Riedel, W; Grohé, C; Gütz, S; Kollmeier, J; Kropf-Sanchen, C; Nimmrich, I; Schnabel, PA; Serke, M; Sieder, C; Thomas, M; Ukena, D; von Pawel, J | 1 |
Gu, FF; Hong, XH; Liang, JY; Liu, L; Liu, YY; Tong, F; Zeng, YL; Zhang, K | 1 |
Damhuis, RA; den Bakker, MA; Derks, JL; Dingemans, AC; Groen, HJ; Smit, EF; Speel, EM; Thunnissen, E; van den Broek, EC; van Suylen, RJ | 1 |
Ando, T; Fujinami, H; Hosokawa, A; Kajiura, S; Matsubara, Y; Mihara, H; Nakata, N; Nanjo, S; Sugiyama, T; Takagi, H; Yoshita, H | 1 |
Motoo, Y | 1 |
Alakus, H; Brunn, A; Bruns, C; Buettner, R; Bunck, A; Daheim, M; Göbel, H; Goeser, T; Hartmann, N; Heydt, C; Kasper, P; Merkelbach-Bruse, S; Plum, P; Quaas, A; Roth, W; Schmidt, M; Tharun, L; Waldschmidt, D; Zander, T | 1 |
Chi, YH; Du, F; Jiang, WC; Song, Y; Sun, YK; Wang, JW; Yang, L; Zhou, AP | 1 |
Angarita, FA; Meek, E; Rodríguez, JL; Sánchez, JO; Tawil, M; Torregrosa, L | 1 |
Duque, M; Gupta, A; Saif, MW | 1 |
Kubushiro, K; Kurasaki, A; Sakurai, N; Takahashi, K; Taoka, H; Yamamoto, Y | 1 |
Ayala, AG; Choi, EK; Divatia, M; Miles, BJ; Okoye, E; Ro, JY | 1 |
Fang, J; Liu, LF; Wu, MJ; Yin, ZM; Yu, AJ; Yu, H; Zhu, JQ | 1 |
Choi, DI; Im, KS; Kwon, YS | 1 |
Brown, J; Burzawa, JK; Byers, LA; Coleman, RL; Frumovitz, M; Munsell, MF; Ramalingam, P | 1 |
Chun, KC; Kim, DY; Kim, JH; Kim, YM; Kim, YT; Nam, JH | 1 |
Adamus, G; Bodurka, DC; Liu, J; Raghunath, A; Schiffman, JS | 1 |
Chen, W; He, Y; Peng, J; Song, W; Zhang, S | 1 |
Dundr, P; Dvorácek, J; Pesl, M; Povýsil, C; Vítková, I | 1 |
Bavieri, M; Bigiani, N; Brambilla, E; Casali, C; Cavazza, A; Fabbri, LM; Facciolongo, N; Longo, L; Maiorana, A; Marchioni, A; Migaldi, M; Morandi, U; Rossi, G; Sartori, G; Schirosi, L | 1 |
Greco, FA; Hainsworth, JD; Litchy, S; Spigel, DR | 1 |
Choomchuay, N; Leelahakorn, S; Manusirivithaya, S; Pataradool, K; Suekwatana, P; Tangjitgamol, S; Thawaramara, T | 1 |
Fujiwara, Y; Kunitoh, H; Nokihara, H; Ohe, Y; Sekine, I; Tamura, T; Tsuta, K; Yamada, K; Yamamoto, N | 1 |
Campbell, LJ; Ellims, PH; Estey, EH; Juneja, SK; Prince, HM; Seymour, JF | 1 |
5 review(s) available for paclitaxel and Carcinoma, Neuroendocrine
Article | Year |
---|---|
[A Case of Neuroendocrine Carcinoma of the Stomach Treated with TAS-102].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Female; Gastrectomy; Humans; Immune Checkpoint Inhibitors; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Nivolumab; Paclitaxel; Stomach Neoplasms | 2022 |
Treatment of poorly differentiated neuroendocrine carcinoma of the pancreas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Etoposide; Humans; Paclitaxel; Pancreatic Neoplasms; Receptor, IGF Type 1; TOR Serine-Threonine Kinases; Treatment Outcome | 2013 |
Ovarian pulmonary-type small cell carcinoma: case report and review of the literature.
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Neuroendocrine; Carcinoma, Ovarian Epithelial; Carcinoma, Small Cell; Carrier Proteins; Female; Humans; Keratins; Lung; Middle Aged; Neoplasms, Glandular and Epithelial; Neural Cell Adhesion Molecules; Ovarian Neoplasms; Paclitaxel; Tomography, X-Ray Computed; Ubiquitin-Protein Ligases | 2013 |
De novo large cell neuroendocrine carcinoma of the prostate gland with pelvic lymph node metastasis: a case report with review of literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Cystoscopy; Disease Progression; Etoposide; Fatal Outcome; Humans; Immunohistochemistry; Laparoscopy; Leuprolide; Lymph Node Excision; Lymphatic Metastasis; Male; Meningeal Neoplasms; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Paclitaxel; Pelvis; Prostatic Neoplasms; Robotic Surgical Procedures; Time Factors; Tomography, X-Ray Computed; Transurethral Resection of Prostate; Treatment Outcome | 2014 |
Secondary acute myeloid leukemia with inv(16): report of two cases following paclitaxel-containing chemotherapy and review of the role of intensified ara-C therapy.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Carcinoma, Neuroendocrine; Chromosome Inversion; Chromosomes, Human, Pair 16; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Myelomonocytic, Acute; Male; Middle Aged; Neoplasms, Second Primary; Ovarian Neoplasms; Paclitaxel; Prognosis; Treatment Outcome | 1999 |
2 trial(s) available for paclitaxel and Carcinoma, Neuroendocrine
Article | Year |
---|---|
Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma: a multicenter phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Everolimus; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Prospective Studies | 2017 |
Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Prospective Studies; Survival Analysis; Treatment Outcome | 2006 |
19 other study(ies) available for paclitaxel and Carcinoma, Neuroendocrine
Article | Year |
---|---|
Paclitaxel-carboplatin plus bevacizumab therapy for advanced neuroendocrine carcinoma of the uterine cervix: A retrospective case series.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Neuroendocrine; Cervix Uteri; Cisplatin; Female; Humans; Paclitaxel; Retrospective Studies; Uterine Cervical Neoplasms | 2023 |
Rare case of tonsillar and subcutaneous metastasis from neuroendocrine cervical cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Fatal Outcome; Female; Humans; Paclitaxel; Tonsillar Neoplasms; Uterine Cervical Neoplasms | 2020 |
Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Albumins; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; ErbB Receptors; Erlotinib Hydrochloride; Fatal Outcome; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Mutation; Paclitaxel | 2017 |
Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Docetaxel; Etoposide; Female; Gemcitabine; Humans; Male; Middle Aged; Netherlands; Paclitaxel; Pemetrexed; Registries; Small Cell Lung Carcinoma; Taxoids; Vinblastine; Vinorelbine | 2017 |
Neuroendocrine Carcinoma of the Stomach: A Response to Combination Chemotherapy Consisting of Ramucirumab Plus Paclitaxel.
Topics: Aged; Anthracyclines; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Neuroendocrine; Cisplatin; Humans; Irinotecan; Male; Paclitaxel; Ramucirumab; Stomach Neoplasms | 2018 |
Ramucirumab Plus Paclitaxel: A Possible New Chemotherapy Regimen for Neuroendocrine Carcinoma of the Stomach.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Humans; Paclitaxel; Ramucirumab; Stomach Neoplasms | 2018 |
Therapy susceptible germline-related BRCA 1-mutation in a case of metastasized mixed adeno-neuroendocrine carcinoma (MANEC) of the small bowel.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; BRCA1 Protein; Carboplatin; Carcinoma, Neuroendocrine; Germ-Line Mutation; Humans; Ileal Neoplasms; Liver Neoplasms; Male; Paclitaxel; Poly(ADP-ribose) Polymerase Inhibitors | 2018 |
[Neuroendocrine tumors: analysis of 252 cases].
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoid Tumor; Carcinoma, Merkel Cell; Carcinoma, Neuroendocrine; Cisplatin; Digestive System Neoplasms; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Palliative Care; Retrospective Studies; Sex Factors; Survival Rate; Young Adult | 2013 |
Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Diagnosis, Differential; Etoposide; Female; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Prognosis; Review Literature as Topic | 2013 |
Effects and toxicity of neoadjuvant chemotherapy preoperative followed by adjuvant chemoradiation in small cell neurdendocrine cervical carcinoma.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Female; Hepatic Insufficiency; Humans; Hysterectomy; Ifosfamide; Middle Aged; Neoadjuvant Therapy; Neutropenia; Paclitaxel; Renal Insufficiency; Thrombocytopenia; Treatment Outcome; Uterine Cervical Neoplasms; Vincristine | 2015 |
Ovarian large cell neuroendocrine carcinoma in the youngest woman.
Topics: Adenocarcinoma, Mucinous; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cytoreduction Surgical Procedures; Fatal Outcome; Female; Humans; Hysterectomy; Multimodal Imaging; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Positron-Emission Tomography; Salpingectomy; Tomography, X-Ray Computed; Treatment Failure | 2016 |
Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Carcinoma, Neuroendocrine; Disease Progression; Disease-Free Survival; Female; Humans; Neoplasm Recurrence, Local; Paclitaxel; Platinum; Retrospective Studies; Survival Rate; Topotecan; Uterine Cervical Neoplasms; Young Adult | 2017 |
Neoadjuvant chemotherapy with paclitaxel plus platinum followed by radical surgery in early cervical cancer during pregnancy: three case reports.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cesarean Section; Female; Humans; Hysterectomy; Magnetic Resonance Imaging; Neoadjuvant Therapy; Paclitaxel; Platinum; Pregnancy; Pregnancy Complications, Neoplastic; Uterine Cervical Neoplasms | 2010 |
Cancer-associated retinopathy in neuroendocrine carcinoma of the fallopian tube.
Topics: Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Neuroendocrine; Fallopian Tube Neoplasms; Female; Humans; Paclitaxel; Positron-Emission Tomography; Retinal Diseases; Visual Acuity; Visual Fields | 2010 |
Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carboplatin; Carcinoma, Neuroendocrine; Cystectomy; Etoposide; Female; Gallbladder Neoplasms; Hepatectomy; Humans; Immunohistochemistry; Liver Neoplasms; Lymph Node Excision; Middle Aged; Neoadjuvant Therapy; Neoplasms, Complex and Mixed; Octreotide; Paclitaxel; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Large cell neuroendocrine carcinoma of the urinary bladder with lymphoepithelioma-like features.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Deoxycytidine; Epithelial Cells; Female; Gemcitabine; Humans; Middle Aged; Paclitaxel; Treatment Outcome; Urinary Bladder Neoplasms; Urologic Surgical Procedures | 2003 |
Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cisplatin; Deoxycytidine; DNA Mutational Analysis; Female; Follow-Up Studies; Gemcitabine; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Paclitaxel; Polymerase Chain Reaction; Proto-Oncogene Proteins c-kit; Proto-Oncogene Proteins c-met; Receptor Protein-Tyrosine Kinases; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Survival Analysis; Survival Rate; Treatment Outcome | 2005 |
Paclitaxel and carboplatin for large cell neuroendocrine carcinoma of the uterine cervix.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Carboplatin; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Fatal Outcome; Female; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Ovariectomy; Paclitaxel; Uterine Cervical Neoplasms | 2007 |
Effect of platinum combined with irinotecan or paclitaxel against large cell neuroendocrine carcinoma of the lung.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Docetaxel; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Retrospective Studies; Taxoids; Vinblastine; Vinorelbine | 2007 |